SRAX (SRAX) Competitors $0.05 0.00 (-1.96%) As of 06/13/2025 10:23 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock SRAX vs. SYRA, UK, DMSL, STBX, APDN, MCOM, ASAP, CTK, MULN, and CAUDShould you be buying SRAX stock or one of its competitors? The main competitors of SRAX include Syra Health (SYRA), Ucommune International (UK), Digital Media Solutions (DMSL), Starbox Group (STBX), Applied DNA Sciences (APDN), Micromobility.com (MCOM), Waitr (ASAP), CooTek (Cayman) (CTK), Mullen Automotive (MULN), and Collective Audience (CAUD). These companies are all part of the "business services" industry. SRAX vs. Its Competitors Syra Health Ucommune International Digital Media Solutions Starbox Group Applied DNA Sciences Micromobility.com Waitr CooTek (Cayman) Mullen Automotive Collective Audience SRAX (NASDAQ:SRAX) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, community ranking, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Which has higher earnings and valuation, SRAX or SYRA? Syra Health has lower revenue, but higher earnings than SRAX. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSRAX$29.29M0.05-$31.64MN/AN/ASyra Health$7.98M0.12-$2.94M-$0.36-0.23 Is SRAX or SYRA more profitable? SRAX has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. SRAX's return on equity of 0.00% beat Syra Health's return on equity.Company Net Margins Return on Equity Return on Assets SRAXN/A N/A N/A Syra Health -54.90%-131.94%-99.19% Do institutionals & insiders have more ownership in SRAX or SYRA? 8.0% of SRAX shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 10.2% of SRAX shares are owned by company insiders. Comparatively, 10.2% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, SRAX or SYRA? SRAX has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, Syra Health has a beta of 3.58, indicating that its share price is 258% more volatile than the S&P 500. Does the media favor SRAX or SYRA? In the previous week, SRAX's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score. Company Overall Sentiment SRAX Neutral Syra Health Neutral Does the MarketBeat Community favor SRAX or SYRA? SRAX received 180 more outperform votes than Syra Health when rated by MarketBeat users. CompanyUnderperformOutperformSRAXOutperform Votes18065.45% Underperform Votes9534.55% Syra HealthN/AN/A SummarySRAX beats Syra Health on 7 of the 10 factors compared between the two stocks. Get SRAX News Delivered to You Automatically Sign up to receive the latest news and ratings for SRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRAX vs. The Competition Export to ExcelMetricSRAXAdvertising agencies IndustryBusiness SectorNASDAQ ExchangeMarket Cap$1.49M$2.03B$14.17B$8.51BDividend YieldN/A4.36%2.58%4.16%P/E RatioN/A77.0333.2919.65Price / Sales0.0529.55313.34152.18Price / CashN/A9.6230.9334.64Price / BookN/A2.345.324.59Net Income-$31.64M$143.63M$194.72M$248.23M7 Day PerformanceN/A-1.33%-2.31%-1.07%1 Month PerformanceN/A0.03%-0.06%2.59%1 Year PerformanceN/A-7.76%22.82%13.50% SRAX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRAXSRAXN/A$0.05-2.0%N/A-85.7%$1.49M$29.29M0.00130SYRASyra HealthN/A$0.09+11.0%N/A-94.6%$1.02M$7.98M-0.1478Gap UpUKUcommune International1.4105 of 5 stars$1.08-1.2%N/A-45.2%$675K$174.62M0.00510Short Interest ↓Gap UpDMSLDigital Media SolutionsN/AN/AN/AN/A$483K$334.95M0.00580STBXStarbox GroupN/A$1.90-18.3%N/A-99.5%$404K$6.17M0.00103High Trading VolumeAPDNApplied DNA Sciences0.5705 of 5 stars$5.17-3.7%$1,125.00+21,660.2%-98.7%$383K$3.79M-0.9070Short Interest ↓Gap DownHigh Trading VolumeMCOMMicromobility.comN/A$0.00-11.1%N/A-64.5%$369K$13.16M0.00360Short Interest ↓Gap UpASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840CTKCooTek (Cayman)N/A$0.03flatN/A+6.5%$151K$272.15M0.00380High Trading VolumeMULNMullen AutomotiveN/A$5.97-6.9%N/A-100.0%$60K$8.93M0.00120Short Interest ↓Gap DownHigh Trading VolumeCAUDCollective AudienceN/A$0.00+214.3%N/A-99.7%$52K$12.14M0.0023Gap Up Related Companies and Tools Related Companies Syra Health Competitors Ucommune International Competitors Digital Media Solutions Competitors Starbox Group Competitors Applied DNA Sciences Competitors Micromobility.com Competitors Waitr Competitors CooTek (Cayman) Competitors Mullen Automotive Competitors Collective Audience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRAX) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SRAX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SRAX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.